PHARM'ACA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARM'ACA
Largest movements
- Cash -€16,025
down €16,025 (-5.3%), from €302,863 to €286,838
mainly Net result for the year (-€18,514) and Other debts (-€4,922)
- Tangible fixed assets -€3,958
down €3,958 (-23.7%), from €16,723 to €12,765
of which Furniture and vehicles: -€3,202
- Profit (loss) carried forward -€18,514
down €18,514 (-61.9%), from -€29,918 to -€48,432
- Other debts -€4,922
down €4,922 (-1.9%), from €263,789 to €258,867
- Trade debts +€3,398
up €3,398 (+580%), from €586 to €3,984
- Gross operating margin -€11,493
down €11,493, from €639 to -€10,854
- Depreciation -€1,326
down €1,326 (-25.1%), from €5,284 to €3,958
- Other operating charges -€237
down €237 (-7.1%), from €3,350 to €3,114
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €321,533 | €301,512 | -€20,021 | -6.2% |
| Fixed assets | 21/28 | €16,723 | €12,765 | -€3,958 | -23.7% |
| Tangible fixed assets | 22/27 | €16,723 | €12,765 | -€3,958 | -23.7% |
| Land and buildings | 22 | €13,521 | €12,765 | -€756 | -5.6% |
| Furniture and vehicles | 24 | €3,202 | €0 | -€3,202 | -100% |
| Current assets | 29/58 | €304,810 | €288,747 | -€16,064 | -5.3% |
| Amounts receivable within one year | 40/41 | €131 | €6 | -€125 | -95.2% |
| Trade receivables | 40 | €131 | €6 | -€125 | -95.2% |
| Cash at bank and in hand | 54/58 | €302,863 | €286,838 | -€16,025 | -5.3% |
| Deferred charges and accrued income | 490/1 | €1,816 | €1,902 | +€86 | +4.7% |
| Total equity and liabilities | 10/49 | €321,533 | €301,512 | -€20,021 | -6.2% |
| Equity | 10/15 | €56,255 | €37,741 | -€18,514 | -32.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €73,773 | €73,773 | = | 0.0% |
| Distributable reserves | 133 | €73,773 | €73,773 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€29,918 | -€48,432 | -€18,514 | -61.9% |
| Amounts payable | 17/49 | €265,279 | €263,771 | -€1,507 | -0.6% |
| Amounts payable within one year | 42/48 | €265,279 | €263,771 | -€1,507 | -0.6% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €586 | €3,984 | +€3,398 | +580% |
| Suppliers | 440/4 | €586 | €3,984 | +€3,398 | +580% |
| Taxes, remuneration and social security | 45 | €903 | €920 | +€16 | +1.8% |
| Taxes | 450/3 | €903 | €920 | +€16 | +1.8% |
| Other amounts payable | 47/48 | €263,789 | €258,867 | -€4,922 | -1.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,284 | €3,958 | -€1,326 | -25.1% |
| Other operating charges | 640/8 | €3,350 | €3,114 | -€237 | -7.1% |
| Gross operating margin | 9900 | €639 | -€10,854 | -€11,493 | |
| Operating profit (loss) | 9901 | -€7,995 | -€17,926 | -€9,931 | -124% |
| Financial income | 75/76B | €9 | €28 | +€19 | +224% |
| Recurring financial income | 75 | €9 | €28 | +€19 | +224% |
| Financial charges | 65/66B | €190 | €150 | -€40 | -21.0% |
| Recurring financial charges | 65 | €190 | €150 | -€40 | -21.0% |
| Profit (loss) for the period before taxes | 9903 | -€8,176 | -€18,048 | -€9,872 | -121% |
| Income taxes | 67/77 | €456 | €466 | +€9 | +2.0% |
| Profit (loss) for the period | 9904 | -€8,633 | -€18,514 | -€9,881 | -114% |
| Profit (loss) for the period to be appropriated | 9905 | -€8,633 | -€18,514 | -€9,881 | -114% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.